Upcoming Education Opportunities
Latest Updates
Epstein-Barr Virus antibodies to differentiate multiple sclerosis from other neuroinflammatory diseases
This multicenter longitudinal case-control study, including a large cohort of pediatric patients, ev…
Paramagnetic rim lesions and central vein sign: role in clinical practice
Tell us your experience!
Spinal cord leptomeningeal enhancement as a marker of extensive spinal cord involvement in children with MOGAD
In this study the presence of spinal cord leptomeningeal enhancement was associated with more extens…
Real-world data on the performance of the 2024 McDonald criteria in children with multiple sclerosis
This recent study showed that the new 2024 McDonald criteria for multiple sclerosis can identify the…
2017-18
FDA approves Gilenya for children and teens with MS; Breakthrough Designation for Pediatric MS.
2016
IPMSSG Neurology supplement